Open-Label Trial of Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Adults ≥50 Years of Age in Mexico

Benzer Materyaller

• Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in adults 50 to 65 years of age in India: An open-label trial
  Yazar:: Solanki, Bhagirath B., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine Coadministered with a Quadrivalent Influenza Vaccine in Adults 50 Years and Older Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
  Yazar:: Baxter, Roger, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged ≥2 Years: An Open-Label Study
  Yazar:: Cordonnier, Catherine, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination
  Yazar:: Bhorat, As’ad E., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
  Yazar:: Shiramoto, Masanari, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)